Trade Erasca Inc - ERAS CFD
What is Erasca Inc (ERAS)?
Erasca Inc is a biotechnology company engaged in the discovery and development of targeted therapies for cancer treatment. The company focuses on precision medicine approaches, utilizing genetic and molecular insights to develop therapies aimed at specific cancer types and patient populations. Its research and development efforts involve identifying novel drug candidates and advancing them through clinical trials. Erasca collaborates with academic institutions, research organizations, and other industry partners to support its pipeline development. The company aims to address unmet medical needs by creating innovative treatments that improve patient outcomes. Its operations include preclinical research, clinical development, regulatory affairs, and commercialization planning. Erasca's strategy emphasizes leveraging scientific expertise and technology platforms to accelerate the development of oncology therapeutics.
Erasca Inc Stock Price Today: Live Overview
The price today is shaped by market trading, with GRAIL Inc at $16.6. Intraday movement has ranged from $16.07 to $16.76, reflecting a daily change of +1.9195%.
FAQ: Erasca Inc (ERAS)
What is the current price of ERAS stock?
Currently, the stock price is $16.6.
Does ERAS pay dividends?
Erasca Inc does not pay dividends.
Does ERAS have a formal corporate presence or regional headquarters in the UAE?
Erasca Inc does not have an official regional office or subsidiary in the UAE and operates through partnerships.
What is ERAS best known for?
The company is most famous for developing targeted therapies for cancer treatment.
What assets are typically shown together with ERAS?
Commonly shown alongside ERAS: Emirates Telecommunications Group Co PJSC, Galaxy Entertainment, fuboTV Inc.
Latest shares articles



